How to reduce morbidity and mortality from chest infections in rheumatoid arthritis
MM Housden, G Bell, CR Heycock, J Hamilton, V Saravanan and CA Kelly
DOI: https://doi.org/10.7861/clinmedicine.10-4-326
Clin Med August 2010 MM Housden
Departments of Medicine and Rheumatology, Queen Elizabeth Foundation Hospital Trust, Gateshead
Roles: Foundation year 1
G Bell
Departments of Medicine and Rheumatology, Queen Elizabeth Foundation Hospital Trust, Gateshead
Roles: Clinical fellow in rheumatology
CR Heycock
Departments of Medicine and Rheumatology, Queen Elizabeth Foundation Hospital Trust, Gateshead
Roles: Consultant rheumatologist
J Hamilton
Departments of Medicine and Rheumatology, Queen Elizabeth Foundation Hospital Trust, Gateshead
Roles: Consultant physician and rheumatologist
V Saravanan
Departments of Medicine and Rheumatology, Queen Elizabeth Foundation Hospital Trust, Gateshead
Roles: Consultant rheumatologist
CA Kelly
Departments of Medicine and Rheumatology, Queen Elizabeth Foundation Hospital Trust, Gateshead
Roles: Consultant physician and rheumatologist
Article Tools
How to reduce morbidity and mortality from chest infections in RA
MM Housden, G Bell, CR Heycock, J Hamilton, V Saravanan, CA Kelly
Clinical Medicine Aug 2010, 10 (4) 326-329; DOI: 10.7861/clinmedicine.10-4-326
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study
- Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate